Form 4: Surrozen CEO Granted Significant Equity Awards

Surrozen, Inc. CEO Craig C. Parker was granted 242,200 employee stock options and 242,200 restricted stock units, vesting over four years.

Summary

• Craig C. Parker, Chief Executive Officer and Director of Surrozen, Inc. (SRZN), received significant equity awards.
• The awards include 242,200 employee stock options with an exercise price of $24.53 per share.
• These options vest in 48 equal monthly installments over a four-year period, commencing February 1, 2026, and have an expiration date of February 16, 2036.
• Additionally, 242,200 Restricted Stock Units (RSUs) were granted, with each RSU representing a contingent right to receive one share of the Issuer's common stock.
• The RSUs vest in four equal annual installments, also starting on February 1, 2026.
• Both the stock options and RSUs are subject to Mr. Parker's continued service through their respective vesting dates.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development, as it signifies strong alignment between the CEO's incentives and long-term shareholder value, while also serving as a key retention mechanism for critical leadership.

Positives

• Significant equity grants to the CEO align his financial interests directly with the long-term value creation for shareholders.
• The structured vesting schedules for both the stock options (48 monthly installments) and RSUs (four annual installments) are designed to promote long-term retention of key leadership.
• The specified exercise price of $24.53 for the options provides a clear incentive for the CEO to drive stock price appreciation above this threshold.

Negatives

• The issuance of 242,200 stock options and 242,200 RSUs represents potential future dilution for existing shareholders upon their vesting and exercise.
• These grants will result in future compensation expenses for the company, which will impact reported profitability metrics.

Risks

• The value of the granted employee stock options and restricted stock units is contingent on the future performance of Surrozen, Inc.'s common stock, meaning the awards could lose value if the stock price declines.
• The vesting of both the stock options and RSUs is subject to Craig C. Parker's continued service through the applicable vesting dates, posing a risk to the full realization of the awards if service is terminated.

Future Outlook

The filing indicates a long-term commitment from the CEO, with equity awards vesting over four years, suggesting an expectation of continued service and contribution to the company's future performance and strategic objectives.

Industry Context

StockSavvy.ai notes that significant equity grants to a CEO are a common practice in the biotechnology and pharmaceutical sectors, particularly for companies like Surrozen, Inc. [SRZN] that are often in development stages. This compensation structure is designed to incentivize long-term value creation and retain key talent in a highly competitive industry.

Comparison to Industry Standards

• Equity compensation packages for CEOs in the biotech industry typically include a mix of stock options and restricted stock units, similar to this grant.
• For example, a CEO at a a comparable-sized biotech firm might receive annual equity grants ranging from 100,000 to 500,000 units, depending on company stage, performance, and market capitalization.
• The four-year vesting schedule is standard for executive equity awards, aligning with best practices for long-term retention and performance incentives.

Related Party Transactions

• This filing details an equity grant from Surrozen, Inc. to its Chief Executive Officer, Craig C. Parker, which is a standard related party transaction for executive compensation.

Stakeholder Impact

• Shareholders: Potential future dilution from the exercise of options and vesting of RSUs, but also increased alignment of the CEO's interests with long-term stock performance.
• Employees: May signal stability in leadership and a commitment to long-term growth, potentially influencing employee morale and retention.
• CEO (Craig C. Parker): Receives significant long-term incentive compensation tied to the company's stock performance and continued service.

Next Steps

• The employee stock options will begin vesting in 48 equal monthly installments from February 1, 2026.
• The restricted stock units will begin vesting in four equal annual installments from February 1, 2026.

Key Dates

Keywords

Surrozen Inc., SRZN, Craig C. Parker, CEO, Director, Employee Stock Option, Restricted Stock Unit, RSU, Equity Grant, Executive Compensation, Insider Transaction, Vesting, Form 4